Patents by Inventor John Pruitt

John Pruitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticulate megestrol formulations
    Patent number: 9044396
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: June 2, 2015
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9040088
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: May 26, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150086635
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: March 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056286
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056287
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20140141083
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 12, 2013
    Publication date: May 22, 2014
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 8512727
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam. The meloxicam particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: August 20, 2013
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20120087955
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 12, 2012
    Inventors: Douglas HOVEY, John Pruitt, Tuula Ryde
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100329976
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 30, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100322853
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100322852
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20100297252
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: May 26, 2010
    Publication date: November 25, 2010
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20100266705
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 29, 2010
    Publication date: October 21, 2010
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Publication number: 20100226989
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 22, 2006
    Publication date: September 9, 2010
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080279949
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: May 9, 2008
    Publication date: November 13, 2008
    Inventors: Elaine MERISKO-LIVERSIDGE, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080226732
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: September 18, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Nanoparticulate compositions of angiogenesis inhibitors
    Publication number: 20080220075
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 11, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Nanoparticulate megestrol formulations
    Publication number: 20080171088
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 17, 2008
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080107741
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 8, 2008
    Inventors: Elaine Merisko-Liversidge, H. Bosch, Greta Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080050461
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 28, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters